Recently, it has also been demonstrated that miR-182-5p targeted PIAS1 (protein inhibitor of activated STAT) mRNA in endometrial cancer, and the overexpression of PIAS1 inhibited Stat3 activity [43]. The gene discussed is STAT3; the disease is endometrial cancer.